Drug Promiscuity of P-glycoprotein and Its Mechanism of Interaction with Paclitaxel and Doxorubicin.

Junqiao Zhang,Tianyang Sun,Lijun Liang,Tao Wu,Qi Wang
DOI: https://doi.org/10.1039/c3sm52499j
IF: 4.046
2013-01-01
Soft Matter
Abstract:P-glycoprotein (P-gp) pumps a broad range of structurally diverse anti-cancer drugs out of cancer cells. Therefore, multi-drug resistance (MDR) in chemotherapy closely correlates with P-gp. However, how this single transport system recognizes different substrates remains unclear. In this study, we attempt to uncover the mechanism of substrate promiscuity of P-gp by atomistic molecular dynamics simulations. Results indicate that different drugs like paclitaxel and doxorubicin approach the putative binding site of P-gp, and the inner residues are found to be important in this process. An obstacle-overcoming process was observed, illustrating that the inner residues are flexible. Interaction energy calculations suggest that the inner residues possess high affinity toward substrates. The cavity of adaptability to accommodate different drugs would help explain why P-gp has so many different substrates.
What problem does this paper attempt to address?